Klaudia Kuranda

2.6k total citations · 1 hit paper
24 papers, 1.7k citations indexed

About

Klaudia Kuranda is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Klaudia Kuranda has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Genetics. Recurrent topics in Klaudia Kuranda's work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (8 papers) and CRISPR and Genetic Engineering (5 papers). Klaudia Kuranda is often cited by papers focused on Virus-based gene therapy research (11 papers), CAR-T cell therapy research (8 papers) and CRISPR and Genetic Engineering (5 papers). Klaudia Kuranda collaborates with scholars based in France, United States and Poland. Klaudia Kuranda's co-authors include Federico Mingozzi, Helena Costa Verdera, Grażyna Palamarczyk, Jean François, Sergueï Sokol, Véronique Le Berre, Bruno Quesnel, Nathalie Jouy, Katherine A. High and Céline Berthon and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

Klaudia Kuranda

24 papers receiving 1.7k citations

Hit Papers

AAV Vector Immunogenicity in Humans: A Long Journey to Su... 2020 2026 2022 2024 2020 100 200 300 400

Peers

Klaudia Kuranda
Uimook Choi United States
David M. Markusic United States
William Osborne United States
G J Rosman United States
Changwon Kang South Korea
John T. Gray United States
Uma Sankar United States
Uimook Choi United States
Klaudia Kuranda
Citations per year, relative to Klaudia Kuranda Klaudia Kuranda (= 1×) peers Uimook Choi

Countries citing papers authored by Klaudia Kuranda

Since Specialization
Citations

This map shows the geographic impact of Klaudia Kuranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaudia Kuranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaudia Kuranda more than expected).

Fields of papers citing papers by Klaudia Kuranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaudia Kuranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaudia Kuranda. The network helps show where Klaudia Kuranda may publish in the future.

Co-authorship network of co-authors of Klaudia Kuranda

This figure shows the co-authorship network connecting the top 25 collaborators of Klaudia Kuranda. A scholar is included among the top collaborators of Klaudia Kuranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaudia Kuranda. Klaudia Kuranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kropf, Elizabeth, et al.. (2024). Complement System Response to Adeno-Associated Virus Vector Gene Therapy. Human Gene Therapy. 35(13-14). 425–438. 15 indexed citations
2.
Xiang, Zhiquan, Klaudia Kuranda, William J. Quinn, et al.. (2022). The Effect of Rapamycin and Ibrutinib on Antibody Responses to Adeno-Associated Virus Vector-Mediated Gene Transfer. Human Gene Therapy. 33(11-12). 614–624. 23 indexed citations
3.
Smith, Corinne J., Nikki L. Ross, Kevin Y. Kim, et al.. (2022). Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood. Frontiers in Immunology. 13. 999021–999021. 48 indexed citations
4.
Tourdot, Sophie, Juliana Bessa, Philippe Broët, et al.. (2020). 10 th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals. mAbs. 12(1). 1725369–1725369. 9 indexed citations
5.
George, Lindsey A., Margaret V. Ragni, John E.J. Rasko, et al.. (2020). Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B. Molecular Therapy. 28(9). 2073–2082. 149 indexed citations
6.
Long, Brian, P. Véron, Klaudia Kuranda, et al.. (2020). Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A. Molecular Therapy. 29(2). 597–610. 54 indexed citations
7.
Verdera, Helena Costa, Klaudia Kuranda, & Federico Mingozzi. (2020). AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer. Molecular Therapy. 28(3). 723–746. 446 indexed citations breakdown →
8.
Xiang, Zhiquan, Raj K. Kurupati, Yan Li, et al.. (2019). The Effect of CpG Sequences on Capsid-Specific CD8+ T Cell Responses to AAV Vector Gene Transfer. Molecular Therapy. 28(3). 771–783. 53 indexed citations
9.
Kuranda, Klaudia, Christian Leborgne, Romain Hardet, et al.. (2018). Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. Journal of Clinical Investigation. 128(12). 5267–5279. 78 indexed citations
10.
Kuranda, Klaudia, Sophie Caillat‐Zucman, Sylvaine You, & Roberto Mallone. (2018). In Vitro Expansion of Anti-viral T Cells from Cord Blood by Accelerated Co-cultured Dendritic Cells. Molecular Therapy — Methods & Clinical Development. 13. 112–120. 2 indexed citations
12.
Djeghloul, Dounia, Klaudia Kuranda, Daniela Barbieri, et al.. (2016). Age-Associated Decrease of the Histone Methyltransferase SUV39H1 in HSC Perturbs Heterochromatin and B Lymphoid Differentiation. Stem Cell Reports. 6(6). 970–984. 77 indexed citations
13.
Kuranda, Klaudia, Céline Berthon, Frédéric Leprêtre, et al.. (2011). Expression of CD34 in hematopoietic cancer cell lines reflects tightly regulated stem/progenitor‐like state. Journal of Cellular Biochemistry. 112(5). 1277–1285. 13 indexed citations
14.
Kuranda, Klaudia, Jacques Vargaftig, Philippe De La Rochère, et al.. (2011). Age-related changes in human hematopoietic stem/progenitor cells. Aging Cell. 10(3). 542–546. 124 indexed citations
15.
Berthon, Céline, Virginie Driss, Jizhong Liu, et al.. (2010). In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Cancer Immunology Immunotherapy. 59(12). 1839–1849. 133 indexed citations
16.
Kuranda, Klaudia, Kariona A. Grabińska, Thierry Bergès, et al.. (2009). TheYTA7gene is involved in the regulation of the isoprenoid pathway in the yeastSaccharomyces cerevisiae. FEMS Yeast Research. 9(3). 381–390. 7 indexed citations
17.
Kuranda, Klaudia, Céline Berthon, Caroline Dupont, et al.. (2009). A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients. Experimental Hematology. 38(2). 124–131.e4. 26 indexed citations
18.
Kuranda, Klaudia, Jean François, & Grażyna Palamarczyk. (2009). The isoprenoid pathway and transcriptional response to its inhibitors in the yeastSaccharomyces cerevisiae. FEMS Yeast Research. 10(1). 14–27. 31 indexed citations
19.
Kuranda, Klaudia, Véronique Le Berre, Sergueï Sokol, Grażyna Palamarczyk, & Jean François. (2006). Investigating the caffeine effects in the yeast Saccharomyces cerevisiae brings new insights into the connection between TOR, PKC and Ras/cAMP signalling pathways. Molecular Microbiology. 61(5). 1147–1166. 172 indexed citations
20.
Riedel, Gerard E., Stephen L. Swanberg, Klaudia Kuranda, et al.. (1990). Denaturing gradient gel electrophoresis identifies genomic DNA polymorphism with high frequency in maize. Theoretical and Applied Genetics. 80(1). 1–10. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026